Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. PCOS is characterized by enlarged ovaries containing multiple small cysts, irregular or absent menstrual periods, excess androgen levels, and polycystic ovaries. Diagnosis of PCOS includes ultrasound, blood tests for reproductive and metabolic hormones, among other procedures.
The Global PCOS Diagnostic Market is estimated to be valued at US$ 3.9 Bn in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the PCOS Diagnostic market are F. Hoffmann-La Roche Ltd, Abbott, Quest Diagnostics, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Hologic, Inc., Vitrolife, Myriad Genetics, Inc., Ansh Labs, Diagnostica Stago Inc., Beckman Coulter, Inc., Randox Laboratories Ltd., GE Healthcare, PrivaPath Diagnostics, Laboratory Corporation of America Holdings, SRL Diagnostics.
Key opportunities in the PCOS Diagnostic Market Demand include increased adoption of innovative diagnostic technologies such as ovarian reserve testing, endometrial biopsy, and three-dimensional ultrasound systems for detecting anatomical abnormalities of the ovaries and uterus. Growth opportunities also lie in increasing awareness regarding early diagnosis of PCOS and availability of diagnostic facilities in developing countries.
Recent advancements in diagnostic technologies such as point-of-care testing devices, artificial intelligence-based diagnostic tools, and user-friendly home monitoring devices are expected to boost the growth of the PCOS diagnostic market.
Market Drivers
Rise in prevalence of infertility and obesity: The increasing incidence of infertility and obesity is a major factor propelling the growth of the PCOS diagnostic market. PCOS is one of the leading causes of infertility which leads to an increased demand for diagnostic tests.
Increased awareness regarding early diagnosis: Growing awareness among women about the importance of early diagnosis of PCOS to curb lifelong health issues has boosted the demand for PCOS diagnostic tests.
Technological advancements: Ongoing R&D leading to development of innovative diagnostic technologies, devices, and tools for easy, affordable and accurate diagnosis of PCOS is expected to drive market growth over the forecast period.
Get more insights on PCOS Diagnostic Market
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian